Gryt Health is a Capability Accelerator

As AI and precision medicine redefine drug development, success depends on activating, not just identifying, patients.

From our community

“I want my voice heard by the pharmaceutical companies.”

Clinical Trial Participant. Gryt Research Member

Activating patients alongside Amgen, Bristol Myers Squibb, Pfizer, Lilly, Takeda and Bayer.

Speakers and attendees of the Gryt Health and Findhelp Integrating Pharma & Social Care Summit
Latest from Gryt

Integrating Pharma & Social Care Summit: Thank You and Takeaways

With Findhelp, we brought pharma, patient advocacy, and community health leaders together to tackle one question: how do we build social care into clinical development and commercial operations, and keep it there?

Read the recap →
Overview

A patient-centered engagement and insights platform. Activating patients and embedding patient voice across the development lifecycle.

Merck KGaA, Darmstadt, Germany panel: Patient-Centered Drug Development, The Role of Digital Literacy in Amplifying Patient Voice, with speakers Nina Siragusa, Hazel Moran, David Craig, Alexandra Kubara and Eduardo Fabiano
Patient-Centered Drug Development Panel

Bioconvergence in practice: what keeps patients from benefiting from digital health innovation?

In November, as part of Global Development Week 2026, Merck KGaA, Darmstadt, Germany hosted a panel on Patient-Centered Drug Development: The Role of Digital Literacy in Amplifying Patient Voice. It brought together patient advocacy, integrated health and medicine, and IT.

Thank you to Hazel Moran, David Craig (GRYT Health), Alexandra Kubara, and Eduardo Fabiano for your perspectives.

Key takeaways from the panel discussion
01
Embed the patient voice across the drug-development continuum, and base decisions on real insights rather than assumptions.
02
Build trust and AI literacy by partnering with patient groups and trusted community voices.
03
Treat AI governance and quality as non-negotiable. AI should augment human support, not replace it in sensitive interactions.
04
Capture lived experience rigorously, especially in rare disease, as an evidence point for faster access to treatment.
Technology succeeds when it is designed with patients, not just for them.
Why Gryt

AI and real-world data are not enough

Gryt’s differentiator is patient engagement and activation built on trust, not transaction. We enable faster patient activation, more credible insights, and differentiation vs. traditional approaches.

Faster Activation

Accelerating recruitment and improving retention by addressing the human barriers AI and data alone cannot solve.

Credible Insights

Moving patient insights upstream to inform strategy, research, and education in a more integrated way.

Authentic Voice

Ensuring the patient voice is authentic, scalable, and defensible to meet regulatory and transparency requirements.

Track record

A decade of activating patients for life sciences leaders

Years of lived-experience intelligence
10+
Partnering with pharma and biotech since 2016.
Scopes of Work Delivered
100
Engaging patients and providers to increase awareness, education, access, and recruitment.
SCOPE Participant Engagement Award
2×
Recognized in 2019 and 2021.
Solutions

From eligibility to participation to evidence

Clinical Trial Patient Activation

Identifying patients isn’t the challenge. Activating them is. CTPA translates protocols into patient-ready journeys and activates patients through trusted channels.

Explore CTPA →

Research & Real-World Evidence

Trusted, authentic patient insights, not just data capture. Advisory boards, patient experience research, and validation of brand strategy and medical education.

See our research →

PACE Council

The Patient Voice Council: a cross-stakeholder network advancing patient-centered AI in engagement, recruitment, and retention, with free tools for IRBs and sponsors.

Meet the Council →

The Advocacy Exchange

A global platform uniting patient advocates, caregivers, nonprofit leaders, researchers, and innovators through monthly livestreams and events.

Join the conversation →
Outcomes

Turning the patient voice into measurable impact

Peer-reviewed publications, abstracts and posters
17+
Patients in Amgen’s BEACON bone health study
200
Regulatory goals achieved for clients
FDA
Testimonials

Trusted by the leaders who develop new medicines, and the patients they serve

“Gryt can find the answers to questions we can’t get from traditional EMR approaches.”
Kimberly Lowe, PhD, MHS
Former Epidemiology Senior Manager, Amgen
“Gryt is an incredible platform to share and learn from our greatest stakeholders: our patients.”
Cathy Florek
Director, Head of Engagement Strategy, Bristol Myers Squibb
“I think your company’s platform is unique and will undoubtedly improve both the OS and QoL for patients.”
Benoit Cadieux, PhD
Former Head Medical Affairs, Amgen
“I want my voice heard by the pharmaceutical companies.”
Patient
Gryt community member